PGDx elio tissue complete CDx lands FDA clearance for melanoma BRAF testing
PGDx launches elio tissue complete CDx for BRAF testing in advanced melanoma, pairing tissue-based companion diagnostics with faster reporting to speed targeted-therapy decisions.